Titan Biotech Ltd — Important, 29-11-2025: Company Update

Titan Biotech's Board has approved a 1:5 stock split. Each equity share with a face value of Rs. 10 will be subdivided into five shares with a face value of Rs. 2. This move aims to enhance stock liquidity and make shares more accessible for retail investors, encouraging broader participation. The company's authorized share capital of Rs. 10 Crore will now be represented by 5 Cr equity shares of Rs. 2 each, altered from 1 Cr shares of Rs. 10 each. This decision requires shareholder approval via postal ballot and is expected to be completed within two months after approval.